-
Silymarin Workflows for Oxidative Stress Research
2026-09-02
Silymarin, a chemically diverse milk thistle extract, supports aligned workflows spanning redox biology, hepatocellular carcinoma, metabolic regulation, and antiviral screening. This guide converts its solubility limits and flavonolignan composition into practical dosing, controls, assay choices, and troubleshooting steps.
-
Ruxolitinib phosphate: JAK1/2 Research Workflows
2026-09-02
Ruxolitinib phosphate (INCB018424) supports controlled studies of JAK1/JAK2-dependent cytokine signaling, inflammation, and tumor-cell fate. This workflow-focused guide connects routine pathway assays with the newer apoptosis, pyroptosis, and mitochondrial findings reported in anaplastic thyroid cancer.
-
Of Chloroquine and COVID-19: Evidence and Limits
2026-09-01
Touret and de Lamballerie’s commentary examines whether chloroquine’s broad in vitro antiviral activity supports its use against SARS-CoV-2. Its central contribution is a comparative reading of cell, animal, and clinical evidence showing that antiviral activity is context-dependent and that immune modulation, toxicity, and failed clinical precedents must temper interpretation.
-
Maternal IL-17A and Risk of Neonatal GBS Disease
2026-09-01
A prospective Moroccan mother–newborn cohort study links reduced maternal IL-17A responses with invasive neonatal Group B Streptococcus disease. By combining cytokine profiling with ex vivo TLR4 and TLR1/2 stimulation, the study proposes maternal IL-17A as a candidate biomarker for identifying pregnancies requiring closer neonatal risk assessment.
-
Hoechst 33342/PI Double Staining Kit Guide
2026-08-31
Learn how SKU K2237 supports reproducible fluorescence-based discrimination of viable, apoptotic, and necrotic cells. This scenario-driven guide covers assay design, protocol optimization, interpretation, and practical vendor selection for Hoechst 33342 propidium iodide staining.
-
Saturated Phosphatidic Acids Drive Hepatic ISR
2026-08-31
The reference study identifies saturated phosphatidic acid production as a mechanistic link between palmitate exposure, mTORC1 activation, and the integrated stress response in hepatocytes. Its findings suggest that high glucose intensifies lipotoxic injury by increasing glycerol-3-phosphate availability for phosphatidic acid synthesis, providing a more specific framework for studying hepatic glucolipotoxicity.
-
αKG–Carnitine Axis in DNA Repair and Drug Resistance
2026-08-30
The reference study identifies an unexpected metabolic mechanism that preserves homologous recombination proficiency in cancer cells: α-ketoglutarate supports TMLHE-dependent carnitine synthesis, which promotes site-specific histone acetylation and DNA double-strand break repair. These findings suggest that disrupting this axis may sensitize otherwise resistant tumors to PARP inhibition, platinum compounds, and radiation.
-
Maternal IL-17A and Neonatal GBS Risk
2026-08-29
A prospective mother–newborn study in Morocco links reduced maternal IL-17A responses with invasive Group B Streptococcus disease in newborns. The findings position circulating maternal IL-17A as a candidate risk biomarker and show how ex vivo pathogen-recognition receptor stimulation can complement clinical surveillance.
-
Rapamycin and mTOR: From Lipotoxicity to Translation
2026-08-28
Rapamycin (Sirolimus) is more than a canonical mTOR inhibitor: it is a mechanistic probe for testing how nutrient stress, proliferation, apoptosis, and immune signaling intersect. This article connects recent PARP-1–mTORC1–p300 findings in palmitate-induced hepatocyte injury with practical assay design, translational positioning, and the limitations researchers should address before moving across disease models.
-
Substance P: Practical Assay Workflows
2026-08-28
Build more reproducible Substance P experiments with disciplined peptide handling, concentration-response design, and orthogonal readouts. A fluorescence-analytics lesson from recent bioaerosol research adds a practical strategy for recognizing and reducing matrix interference without overstating what the reference study proves.
-
Bestatin Hydrochloride for Mechanistic Assays
2026-08-27
Bestatin hydrochloride, also called Ubenimex, helps researchers connect aminopeptidase activity with neuronal signaling, endothelial tube formation, and tumor biology. This guide translates the reference study into practical assay designs, control strategies, and troubleshooting steps for angiogenesis inhibition and cancer research.
-
P2Y11 Antagonist NF 340 for Invasion Assays
2026-08-27
NF 340 is a receptor-proximal tool for testing how P2Y11 signaling connects QPRT activity with cytoskeletal remodeling and breast cancer cell invasion. This practical guide covers assay design, pathway-positioning experiments, solution handling, and troubleshooting for reproducible mechanistic studies.
-
Partial BACE Inhibition Preserves Synaptic Function
2026-08-26
Satir et al. showed that moderate β-secretase inhibition can reduce amyloid β secretion without impairing synaptic transmission in primary cortical rat neurons. The study defines an experimentally supported boundary between partial and stronger BACE inhibition, informing strategies aimed at lowering amyloid production while limiting synaptic toxicity.
-
Isochlorogenic acid A for Hydrogel Wound Research
2026-08-26
Isochlorogenic acid A links natural-product chemistry with practical anti-infection, immunology, and inflammation research. Its Fe3+-coassembled nanoparticle format offers a strategy for overcoming poor water solubility while enabling hydrogel-based wound assays.
-
Tofacitinib Rewires RA Macrophage Immunometabolism
2026-08-25
Tofacitinib (CP-690550, Tasocitinib) offers translational researchers more than pathway inhibition: in GM-CSF-reprogrammed rheumatoid arthritis macrophages, it links JAK/STAT perturbation to inflammatory resolution and mitochondrial repair. This thought-leadership guide translates those findings into assay design, competitive strategy, and evidence-led immune modulation research.